DE105866C - - Google Patents
Info
- Publication number
- DE105866C DE105866C DE1897105866D DE105866DA DE105866C DE 105866 C DE105866 C DE 105866C DE 1897105866 D DE1897105866 D DE 1897105866D DE 105866D A DE105866D A DE 105866DA DE 105866 C DE105866 C DE 105866C
- Authority
- DE
- Germany
- Prior art keywords
- silver
- solution
- protein
- compounds
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NDVLTYZPCACLMA-UHFFFAOYSA-N Silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 150000003379 silver compounds Chemical class 0.000 claims description 6
- 229940027985 antiseptics and disinfectants Silver compounds Drugs 0.000 claims description 5
- 229940100890 silver compounds Drugs 0.000 claims description 5
- 229910001923 silver oxide Inorganic materials 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 17
- 239000002244 precipitate Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 108010082714 Silver Proteins Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000003378 silver Chemical class 0.000 description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N Silver nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102100001249 ALB Human genes 0.000 description 1
- 101710027066 ALB Proteins 0.000 description 1
- 229940064004 Antiseptic throat preparations Drugs 0.000 description 1
- 208000001786 Gonorrhea Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 210000004400 Mucous Membrane Anatomy 0.000 description 1
- 229940066779 Peptones Drugs 0.000 description 1
- 101710024753 SERPINB14 Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- -1 albumoses Proteins 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000002421 anti-septic Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000010956 nickel silver Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT1304D AT1304B (no) | 1897-08-04 | 1899-08-02 | |
| AT6653D AT6653B (no) | 1897-08-04 | 1901-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE105866C true DE105866C (no) |
Family
ID=376105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1897105866D Expired - Lifetime DE105866C (no) | 1897-08-04 | 1897-08-04 |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE105866C (no) |
-
1897
- 1897-08-04 DE DE1897105866D patent/DE105866C/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2501787C2 (no) | ||
| DE105866C (no) | ||
| DE1168441B (de) | Verfahren zur Herstellung einer Polyaminopolyessigsaeure und ihrer komplexen Metallverbindungen | |
| DE118496C (no) | ||
| DE255030C (no) | ||
| DE82951C (no) | ||
| DE407167C (de) | Verfahren zur Herstellung von Vertilgungsmitteln fuer Pflanzenschaedlinge | |
| DE479229C (de) | Verfahren zur Herstellung von Kupfer-, Zink- und Magnesiumsalzen des Tannins | |
| AT7856B (de) | Verfahren zur Darstellung von leicht löslichen Silberverbindungen der Proteïnstoffe. | |
| DE647056C (de) | Verfahren zur Herstellung von Verbindungen aus Hexamethylentetraminrhodanid | |
| DE487726C (de) | Verfahren zur Herstellung organischer Quecksilberverbindungen | |
| DE261875C (no) | ||
| DE124680C (no) | ||
| DE565065C (de) | Verfahren zur getrennten Gewinnung einer blutdruckerhoehenden Substanz und einer aufden Uterusmuskel zusammenziehend wirkenden Substanz aus dem Hypophysenhinterlappen | |
| DE130495C (no) | ||
| DE266655C (no) | ||
| DE702185C (de) | hen Calciumdoppelsalzen der Ascorbinsaeure | |
| DE488891C (de) | Verfahren zur Darstellung von N-substituierten Arsenobenzimidazolonen | |
| DE100874C (no) | ||
| DE172932C (no) | ||
| DE185197C (no) | ||
| DE601995C (de) | Verfahren zur Darstellung von komplexen Antimonverbindungen | |
| DE386691C (de) | Verfahren zur Herstellung von Derivaten des Hexamethylentetramins | |
| DE650221C (de) | Verfahren zur Herstellung wasserloeslicher komplexer Alkalirhodiumnitrite | |
| DE188435C (no) |